These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 2855615

  • 1. A prototype vaccine to prevent Epstein-Barr virus-associated cancers.
    Epstein M.
    Chemioterapia; 1987 Jun; 6(2 Suppl):655-8. PubMed ID: 2855615
    [No Abstract] [Full Text] [Related]

  • 2. Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.
    Epstein MA, Morgan AJ.
    Clin Exp Immunol; 1983 Aug; 53(2):257-71. PubMed ID: 6309441
    [No Abstract] [Full Text] [Related]

  • 3. [Viruses and human cancers: fundamental aspects and hopes of prevention].
    de Thé G.
    C R Seances Soc Biol Fil; 1986 Aug; 180(3):249-61. PubMed ID: 3022897
    [No Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus. Is it timely to discuss a vaccine?
    Biomedicine; 1978 Aug; 28(1):15-7. PubMed ID: 208671
    [No Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus (EBV). IV. Studies on experimental inactivated vaccine against human EBV infection.
    Pătraşcu IV, Tache M.
    Virologie; 1988 Aug; 39(1):29-33. PubMed ID: 2837001
    [Abstract] [Full Text] [Related]

  • 6. Implications of a vaccine for the prevention of Epstein-Barr virus infection: ethical and logistic considerations.
    Epstein MA.
    Cancer Res; 1976 Feb; 36(2 pt 2):711-4. PubMed ID: 175931
    [Abstract] [Full Text] [Related]

  • 7. The Leeuwenhoek lecture, 1983. A prototype vaccine to prevent Epstein-Barr virus-associated tumours.
    Epstein MA.
    Proc R Soc Lond B Biol Sci; 1984 Mar 22; 221(1222):1-20. PubMed ID: 6144103
    [Abstract] [Full Text] [Related]

  • 8. Issues related to development of Epstein-Barr virus vaccines.
    Spring SB, Hascall G, Gruber J.
    J Natl Cancer Inst; 1996 Oct 16; 88(20):1436-41. PubMed ID: 8841018
    [No Abstract] [Full Text] [Related]

  • 9. Not all potently neutralizing, vaccine-induced antibodies to Epstein-Barr virus ensure protection of susceptible experimental animals.
    Epstein MA, Randle BJ, Finerty S, Kirkwood JK.
    Clin Exp Immunol; 1986 Mar 16; 63(3):485-90. PubMed ID: 3011324
    [Abstract] [Full Text] [Related]

  • 10. [The laboratory diagnosis of infections associated with Epstein-Barr Virus].
    Morag A.
    Harefuah; 1982 Mar 15; 102(6):247-50. PubMed ID: 6298077
    [No Abstract] [Full Text] [Related]

  • 11. Prospects of vaccines against cancer in man.
    Bey EM.
    S Afr Med J; 1978 Jul 29; 54(5):189-92. PubMed ID: 212839
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus--is it time to develop a vaccine program?
    Epstein MA.
    J Natl Cancer Inst; 1976 Apr 29; 56(4):697-700. PubMed ID: 176406
    [No Abstract] [Full Text] [Related]

  • 13. Vaccination against EB virus.
    Br Med J; 1976 Dec 18; 2(6050):1467-8. PubMed ID: 187278
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Liposomal subunit vaccine against Epstein-Barr virus-induced malignant lymphoma.
    Gregoriadis G.
    Nature; 1976 Dec 18; 320(6057):87-8. PubMed ID: 3005876
    [No Abstract] [Full Text] [Related]

  • 17. [Epstein-Barr virus infection: immunology and immunopathology].
    Geelen SP, Kuis W, Roord JJ, Stoop JW, Kapsenberg JG.
    Ned Tijdschr Geneeskd; 1986 Jan 11; 130(2):63-7. PubMed ID: 3005887
    [No Abstract] [Full Text] [Related]

  • 18. [New perspectives in the search for a vaccine against the Epstein-Barr virus].
    Cour Boveda MI, Yagüe García V.
    An Med Interna; 1991 Nov 11; 8(11):527-8. PubMed ID: 1665087
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevention of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes.
    Morgan AJ, Finerty S, Lovgren K, Scullion FT, Morein B.
    J Gen Virol; 1988 Aug 11; 69 ( Pt 8)():2093-6. PubMed ID: 2841417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.